S.B. No. 449

	AN ACT
	relating to the penalty group classification of certain controlled
	substances.
	BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
	SECTION 1.  Section 481.102, Health and Safety Code, is
	amended to read as follows:
	Sec. 481.102.  PENALTY GROUP 1. Penalty Group 1 consists of:
	(1)  the following opiates, including their isomers,
	esters, ethers, salts, and salts of isomers, esters, and ethers,
	unless specifically excepted, if the existence of these isomers,
	esters, ethers, and salts is possible within the specific chemical
	designation:
	Alfentanil;
	Allylprodine;
	Alphacetylmethadol;
	Benzethidine;
	Betaprodine;
	Clonitazene;
	Diampromide;
	Diethylthiambutene;
	Difenoxin not listed in Penalty Group 3 or 4;
	Dimenoxadol;
	Dimethylthiambutene;
	Dioxaphetyl butyrate;
	Dipipanone;
	Ethylmethylthiambutene;
	Etonitazene;
	Etoxeridine;
	Furethidine;
	Hydroxypethidine;
	Ketobemidone;
	Levophenacylmorphan;
	Meprodine;
	Methadol;
	Moramide;
	Morpheridine;
	Noracymethadol;
	Norlevorphanol;
	Normethadone;
	Norpipanone;
	Phenadoxone;
	Phenampromide;
	Phenomorphan;
	Phenoperidine;
	Piritramide;
	Proheptazine;
	Properidine;
	Propiram;
	Sufentanil;
	Tilidine; and
	Trimeperidine;
	(2)  the following opium derivatives, their salts,
	isomers, and salts of isomers, unless specifically excepted, if the
	existence of these salts, isomers, and salts of isomers is possible
	within the specific chemical designation:
	Acetorphine;
	Acetyldihydrocodeine;
	Benzylmorphine;
	Codeine methylbromide;
	Codeine-N-Oxide;
	Cyprenorphine;
	Desomorphine;
	Dihydromorphine;
	Drotebanol;
	Etorphine, except hydrochloride salt;
	Heroin;
	Hydromorphinol;
	Methyldesorphine;
	Methyldihydromorphine;
	Monoacetylmorphine;
	Morphine methylbromide;
	Morphine methylsulfonate;
	Morphine-N-Oxide;
	Myrophine;
	Nicocodeine;
	Nicomorphine;
	Normorphine;
	Pholcodine; and
	Thebacon;
	(3)  the following substances, however produced,
	except those narcotic drugs listed in another group:
	(A)  Opium and opiate not listed in Penalty Group
	3 or 4, and a salt, compound, derivative, or preparation of opium or
	opiate, other than thebaine derived butorphanol, nalmefene and its
	salts, naloxone and its salts, and naltrexone and its salts, but
	including:
	Codeine not listed in Penalty Group 3 or 4;
	Dihydroetorphine;
	Ethylmorphine not listed in Penalty Group 3
	or 4;
	Granulated opium;
	Hydrocodone not listed in Penalty Group 3;
	Hydromorphone;
	Metopon;
	Morphine not listed in Penalty Group 3;
	Opium extracts;
	Opium fluid extracts;
	Oripavine;
	Oxycodone;
	Oxymorphone;
	Powdered opium;
	Raw opium;
	Thebaine; and
	Tincture of opium;
	(B)  a salt, compound, isomer, derivative, or
	preparation of a substance that is chemically equivalent or
	identical to a substance described by Paragraph (A), other than the
	isoquinoline alkaloids of opium;
	(C)  Opium poppy and poppy straw;
	(D)  Cocaine, including:
	(i)  its salts, its optical, position, and
	geometric isomers, and the salts of those isomers;
	(ii)  coca leaves and a salt, compound,
	derivative, or preparation of coca leaves;
	(iii)  a salt, compound, derivative, or
	preparation of a salt, compound, or derivative that is chemically
	equivalent or identical to a substance described by Subparagraph
	(i) or (ii), other than decocainized coca leaves or extractions of
	coca leaves that do not contain cocaine or ecgonine; and
	(E)  concentrate of poppy straw, meaning the crude
	extract of poppy straw in liquid, solid, or powder form that
	contains the phenanthrine alkaloids of the opium poppy;
	(4)  the following opiates, including their isomers,
	esters, ethers, salts, and salts of isomers, if the existence of
	these isomers, esters, ethers, and salts is possible within the
	specific chemical designation:
	Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-
	phenethyl)-4-piperidinyl]-N-phenylacetamide);
	Alpha-methylthiofentanyl (N-[1-methyl-2-(2-
	thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
	Alphaprodine;
	Anileridine;
	Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-
	phenethyl)-4-piperidinyl] -N-phenylpropanamide);
	Beta-hydroxy-3-methylfentanyl;
	Bezitramide;
	Carfentanil;
	Dihydrocodeine not listed in Penalty Group 3 or 4;
	Diphenoxylate not listed in Penalty Group 3 or 4;
	Fentanyl or alpha-methylfentanyl, or any other
	derivative of Fentanyl;
	Isomethadone;
	Levomethorphan;
	Levorphanol;
	Metazocine;
	Methadone;
	Methadone-Intermediate, 4-cyano-2-dimethylamino-
	4, 4-diphenyl butane;
	3-methylfentanyl(N-[3-methyl-1-(2-phenylethyl)-
	4-piperidyl]-N-phenylpropanamide);
	3-methylthiofentanyl(N-[3-methyl-1-(2-thienyl)
	ethyl-4-piperidinyl]-N-phenylpropanamide);
	Moramide-Intermediate, 2-methyl-3-morpholino-1,
	1-diphenyl-propane-carboxylic acid;
	Para-fluorofentanyl(N-(4-fluorophenyl)-N-1-(2-
	phenylethyl)-4-piperidinylpropanamide);
	PEPAP (1-(2-phenethyl)-4-phenyl-4-
	acetoxypiperidine);
	Pethidine (Meperidine);
	Pethidine-Intermediate-A, 4-cyano-1-methyl-4-
	phenylpiperidine;
	Pethidine-Intermediate-B, ethyl-4-
	phenylpiperidine-4 carboxylate;
	Pethidine-Intermediate-C, 1-methyl-4-
	phenylpiperidine-4-carboxylic acid;
	Phenazocine;
	Piminodine;
	Racemethorphan;
	Racemorphan;
	Remifentanil; and
	Thiofentanyl(N-phenyl-N-[1-(2-thienyl)ethyl-4-pi
	peridinyl]-propanamide);
	(5)  Flunitrazepam (trade or other name: Rohypnol);
	(6)  Methamphetamine, including its salts, optical
	isomers, and salts of optical isomers;
	(7)  Phenylacetone and methylamine, if possessed
	together with intent to manufacture methamphetamine;
	(8)  Phencyclidine, including its salts;
	(9)  Gamma hydroxybutyric acid (some trade or other
	names: gamma hydroxybutyrate, GHB), including its salts; and
	(10)  Ketamine.
	SECTION 2.  Subsection (a), Section 481.103, Health and
	Safety Code, is amended to read as follows:
	(a)  Penalty Group 2 consists of:
	(1)  any quantity of the following hallucinogenic
	substances, their salts, isomers, and salts of isomers, unless
	specifically excepted, if the existence of these salts, isomers,
	and salts of isomers is possible within the specific chemical
	designation:
	alpha-ethyltryptamine;
	alpha-methyltryptamine;
	4-bromo-2, 5-dimethoxyamphetamine (some trade or
	other names: 4-bromo-2, 5-dimethoxy-alpha-methylphenethylamine;
	4-bromo-2, 5-DMA);
	4-bromo-2, 5-dimethoxyphenethylamine;
	Bufotenine (some trade and other names: 3-(beta-
	Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)- 5-
	indolol; N, N-dimethylserotonin; 5-hydroxy-N, N-
	dimethyltryptamine; mappine);
	Diethyltryptamine (some trade and other names: N,
	N-Diethyltryptamine, DET);
	2, 5-dimethoxyamphetamine (some trade or other
	names: 2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA);
	2, 5-dimethoxy-4-ethylamphetamine (trade or other
	name: DOET);
	2, 5-dimethoxy-4-(n)-propylthiophenethylamine
	(trade or other name: 2C-T-7);
	Dimethyltryptamine ( trade or other name: DMT);
	Dronabinol (synthetic) in sesame oil and
	encapsulated in a soft gelatin capsule in a U.S. Food and Drug
	Administration approved drug product (some trade or other names for
	Dronabinol: (a6aR-trans)-6a,7,8,10a-tetrahydro- 6,6, 9-
	trimethyl-3-pentyl-6H- dibenzo [b,d]pyran-1-ol or (-)-delta-9-
	(trans)- tetrahydrocannabinol);
	Ethylamine Analog of Phencyclidine (some trade or
	other names: N-ethyl-1-phenylcyclohexylamine, (1-
	phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine,
	cyclohexamine, PCE);
	Ibogaine (some trade or other names: 7-Ethyl-6,
	6, beta 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H-
	pyrido [1', 2':1, 2] azepino [5, 4-b] indole; tabernanthe iboga.);
	Mescaline;
	5-methoxy-N, N-diisopropyltryptamine;
	5-methoxy-3, 4-methylenedioxy amphetamine;
	4-methoxyamphetamine (some trade or other names:
	4-methoxy-alpha-methylphenethylamine; paramethoxyamphetamine;
	PMA);
	1-methyl- 4-phenyl-4-propionoxypiperidine (MPPP,
	PPMP);
	4-methyl-2, 5-dimethoxyamphetamine (some trade
	and other names: 4-methyl-2, 5-dimethoxy-alpha-
	methylphenethylamine; "DOM"; "STP");
	3,4-methylenedioxy methamphetamine (MDMA, MDM);
	3,4-methylenedioxy amphetamine;
	3,4-methylenedioxy N-ethylamphetamine (Also
	known as N-ethyl MDA);
	Nabilone (Another name for nabilone: (+)-trans-
	3-(1,1-dimethylheptyl)- 6,6a, 7,8,10,10a-hexahydro-1-hydroxy- 6,
	6-dimethyl-9H-dibenzo[b,d] pyran-9-one;
	N-benzylpiperazine (some trade or other names:
	BZP; 1-benzylpiperazine);
	N-ethyl-3-piperidyl benzilate;
	N-hydroxy-3,4-methylenedioxyamphetamine (Also
	known as N-hydroxy MDA);
	4-methylaminorex;
	N-methyl-3-piperidyl benzilate;
	Parahexyl (some trade or other names: 3-Hexyl-1-
	hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo [b, d]
	pyran; Synhexyl);
	1-Phenylcyclohexylamine;
	1-Piperidinocyclohexanecarbonitrile (PCC);
	Psilocin;
	Psilocybin;
	Pyrrolidine Analog of Phencyclidine (some trade
	or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP);
	Tetrahydrocannabinols, other than marihuana, and
	synthetic equivalents of the substances contained in the plant, or
	in the resinous extractives of Cannabis, or synthetic substances,
	derivatives, and their isomers with similar chemical structure and
	pharmacological activity such as:
	delta-1 cis or trans tetrahydrocannabinol,
	and their optical isomers;
	delta-6 cis or trans tetrahydrocannabinol,
	and their optical isomers;
	delta-3, 4 cis or trans
	tetrahydrocannabinol, and its optical isomers;
	compounds of these structures, regardless of
	numerical designation of atomic positions, since nomenclature of
	these substances is not internationally standardized;
	Thiophene Analog of Phencyclidine (some trade or
	other names: 1-[1-(2-thienyl) cyclohexyl] piperidine; 2-Thienyl
	Analog of Phencyclidine; TPCP, TCP);
	1-pyrrolidine (some trade or other name: TCPy);
	1-(3-trifluoromethylphenyl)piperazine (trade or
	other name: TFMPP); and
	3,4,5-trimethoxy amphetamine;
	(2)  Phenylacetone (some trade or other names:
	Phenyl-2-propanone; P2P, Benzymethyl ketone, methyl benzyl
	ketone); and
	(3)  unless specifically excepted or unless listed in
	another Penalty Group, a material, compound, mixture, or
	preparation that contains any quantity of the following substances
	having a potential for abuse associated with a depressant or
	stimulant effect on the central nervous system:
	Aminorex (some trade or other names: aminoxaphen;
	2-amino-5-phenyl-2-oxazoline; 4,5-dihydro-5-
	phenyl-2-oxazolamine);
	Amphetamine, its salts, optical isomers, and
	salts of optical isomers;
	Cathinone (some trade or other names: 2-amino-1-
	phenyl-1-propanone, alpha-aminopropiophenone, 2-
	aminopropiophenone);
	Etorphine Hydrochloride;
	Fenethylline and its salts;
	Lisdexamfetamine, including its salts, isomers,
	and salts of isomers;
	Mecloqualone and its salts;
	Methaqualone and its salts;
	Methcathinone (some trade or other names: 2-
	methylamino-propiophenone; alpha-(methylamino)propriophenone;
	2-(methylamino)-1-phenylpropan-1-one; alpha-N-
	methylaminopropriophenone; monomethylpropion; ephedrone, N-
	methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and UR
	1431);
	N-Ethylamphetamine, its salts, optical isomers,
	and salts of optical isomers; and
	N,N-dimethylamphetamine (some trade or other
	names: N,N,alpha-trimethylbenzeneethaneamine;
	N,N,alpha-trimethylphenethylamine), its salts, optical isomers,
	and salts of optical isomers.
	SECTION 3.  Subsection (a), Section 481.104, Health and
	Safety Code, is amended to read as follows:
	(a)  Penalty Group 3 consists of:
	(1)  a material, compound, mixture, or preparation that
	contains any quantity of the following substances having a
	potential for abuse associated with a stimulant effect on the
	central nervous system:
	Methylphenidate and its salts; and
	Phenmetrazine and its salts;
	(2)  a material, compound, mixture, or preparation that
	contains any quantity of the following substances having a
	potential for abuse associated with a depressant effect on the
	central nervous system:
	a substance that contains any quantity of a
	derivative of barbituric acid, or any salt of a derivative of
	barbituric acid not otherwise described by this subsection;
	a compound, mixture, or preparation containing
	amobarbital, secobarbital, pentobarbital, or any salt of any of
	these, and one or more active medicinal ingredients that are not
	listed in any penalty group;
	a suppository dosage form containing amobarbital,
	secobarbital, pentobarbital, or any salt of any of these drugs, and
	approved by the United States Food and Drug Administration for
	marketing only as a suppository;
	Alprazolam;
	Amobarbital;
	Bromazepam;
	Camazepam;
	Chlordiazepoxide;
	Chlorhexadol;
	Clobazam;
	Clonazepam;
	Clorazepate;
	Clotiazepam;
	Cloxazolam;
	Delorazepam;
	Diazepam;
	Estazolam;
	Ethyl loflazepate;
	Fludiazepam;
	Flurazepam;
	Glutethimide;
	Halazepam;
	Haloxzolam;
	Ketazolam;
	Loprazolam;
	Lorazepam;
	Lormetazepam;
	Lysergic acid, including its salts, isomers, and
	salts of isomers;
	Lysergic acid amide, including its salts,
	isomers, and salts of isomers;
	Mebutamate;
	Medazepam;
	Methyprylon;
	Midazolam;
	Nimetazepam;
	Nitrazepam;
	Nordiazepam;
	Oxazepam;
	Oxazolam;
	Pentazocine, its salts, derivatives, or compounds
	or mixtures thereof;
	Pentobarbital;
	Pinazepam;
	Prazepam;
	Quazepam;
	Secobarbital;
	Sulfondiethylmethane;
	Sulfonethylmethane;
	Sulfonmethane;
	Temazepam;
	Tetrazepam;
	Tiletamine and zolazepam in combination, and its
	salts. (some trade or other names for a tiletamine-zolazepam
	combination product: Telazol, for tiletamine: 2-(ethylamino)-
	2-(2-thienyl)-cyclohexanone, and for zolazepam: 4-(2-
	fluorophenyl)-6, 8-dihydro-1,3,8,-trimethylpyrazolo-[3,4-
	e](1,4)-d diazepin-7(1H)-one, flupyrazapon);
	Triazolam;
	Zaleplon; [and]
	Zolpidem; and
	Zopiclone;
	(3)  Nalorphine;
	(4)  a material, compound, mixture, or preparation
	containing limited quantities of the following narcotic drugs, or
	any of their salts:
	not more than 1.8 grams of codeine, or any of its
	salts, per 100 milliliters or not more than 90 milligrams per dosage
	unit, with an equal or greater quantity of an isoquinoline alkaloid
	of opium;
	not more than 1.8 grams of codeine, or any of its
	salts, per 100 milliliters or not more than 90 milligrams per dosage
	unit, with one or more active, nonnarcotic ingredients in
	recognized therapeutic amounts;
	not more than 300 milligrams of dihydrocodeinone
	(hydrocodone), or any of its salts, per 100 milliliters or not more
	than 15 milligrams per dosage unit, with a fourfold or greater
	quantity of an isoquinoline alkaloid of opium;
	not more than 300 milligrams of dihydrocodeinone
	(hydrocodone), or any of its salts, per 100 milliliters or not more
	than 15 milligrams per dosage unit, with one or more active,
	nonnarcotic ingredients in recognized therapeutic amounts;
	not more than 1.8 grams of dihydrocodeine, or any
	of its salts, per 100 milliliters or not more than 90 milligrams per
	dosage unit, with one or more active, nonnarcotic ingredients in
	recognized therapeutic amounts;
	not more than 300 milligrams of ethylmorphine, or
	any of its salts, per 100 milliliters or not more than 15 milligrams
	per dosage unit, with one or more active, nonnarcotic ingredients
	in recognized therapeutic amounts;
	not more than 500 milligrams of opium per 100
	milliliters or per 100 grams, or not more than 25 milligrams per
	dosage unit, with one or more active, nonnarcotic ingredients in
	recognized therapeutic amounts;
	not more than 50 milligrams of morphine, or any of
	its salts, per 100 milliliters or per 100 grams with one or more
	active, nonnarcotic ingredients in recognized therapeutic amounts;
	and
	not more than 1 milligram of difenoxin and not
	less than 25 micrograms of atropine sulfate per dosage unit;
	(5)  a material, compound, mixture, or preparation that
	contains any quantity of the following substances:
	Barbital;
	Chloral betaine;
	Chloral hydrate;
	Ethchlorvynol;
	Ethinamate;
	Meprobamate;
	Methohexital;
	Methylphenobarbital (Mephobarbital);
	Paraldehyde;
	Petrichloral; and
	Phenobarbital;
	(6)  Peyote, unless unharvested and growing in its
	natural state, meaning all parts of the plant classified
	botanically as Lophophora, whether growing or not, the seeds of the
	plant, an extract from a part of the plant, and every compound,
	manufacture, salt, derivative, mixture, or preparation of the
	plant, its seeds, or extracts;
	(7)  unless listed in another penalty group, a
	material, compound, mixture, or preparation that contains any
	quantity of the following substances having a stimulant effect on
	the central nervous system, including the substance's salts,
	optical, position, or geometric isomers, and salts of the
	substance's isomers, if the existence of the salts, isomers, and
	salts of isomers is possible within the specific chemical
	designation:
	Benzphetamine;
	Cathine [(+)-norpseudoephedrine];
	Chlorphentermine;
	Clortermine;
	Diethylpropion;
	Fencamfamin;
	Fenfluramine;
	Fenproporex;
	Mazindol;
	Mefenorex;
	Modafinil;
	Pemoline (including organometallic complexes and
	their chelates);
	Phendimetrazine;
	Phentermine;
	Pipradrol;
	Sibutramine; and
	SPA [(-)-1-dimethylamino-1,2-diphenylethane];
	(8)  unless specifically excepted or unless listed in
	another penalty group, a material, compound, mixture, or
	preparation that contains any quantity of the following substance,
	including its salts:
	Dextropropoxyphene (Alpha-(+)-4-dimethylamino-
	1,2-diphenyl-3-methyl-2-propionoxybutane); and
	(9)  an anabolic steroid, including any drug or
	hormonal substance, or any substance that is chemically or
	pharmacologically related to testosterone, other than an estrogen,
	progestin, dehydroepiandrosterone, or corticosteroid, and promotes
	muscle growth, including the following drugs and substances and any
	salt, ester, or ether of the following drugs and substances:
	Androstanediol;
	Androstanedione;
	Androstenediol;
	Androstenedione;
	Bolasterone;
	Boldenone;
	Calusterone;
	[Chlorotestosterone (4-chlortestosterone);]
	Clostebol;
	Dehydrochlormethyltestosterone;
	Delta-1-dihydrotestosterone;
	Dihydrotestosterone (4-dihydrotestosterone);
	Drostanolone;
	Ethylestrenol;
	Fluoxymesterone;
	Formebulone;
	Furazabol;
	13beta-ethyl-17beta-hydroxygon-4-en-3-one;
	4-hydroxytestosterone;
	4-hydroxy-19-nortestosterone;
	Mestanolone;
	Mesterolone;
	Methandienone;
	[Methandranone;]
	Methandriol;
	[Methandrostenolone;]
	Methenolone;
	17alpha-methyl-3beta, 17 beta-dihydroxy-5alpha-
	androstane;
	17alpha-methyl-3alpha, 17 beta-dihydroxy-5alpha-
	androstane;
	17alpha-methyl-3beta, 17beta-dihydroxyandrost-4-
	ene;
	17alpha-methyl-4-hydroxynandrolone;
	Methyldienolone;
	Methyltestosterone;
	Methyltrienolone;
	17alpha-methyl-delta-1-dihydrotestosterone;
	Mibolerone;
	Nandrolone;
	Norandrostenediol;
	Norandrostenedione;
	Norbolethone;
	Norclostebol;
	Norethandrolone;
	Normethandrolone;
	Oxandrolone;
	Oxymesterone;
	Oxymetholone;
	[Stanolone;]
	Stanozolol;
	Stenbolone;
	Testolactone;
	Testosterone;
	Tetrahydrogestrinone; and
	Trenbolone.
	SECTION 4.  The change in law made by this Act applies only
	to an offense committed on or after the effective date of this Act.
	An offense committed before the effective date of this Act is
	covered by the law in effect when the offense was committed, and the
	former law is continued in effect for that purpose. For purposes of
	this section, an offense was committed before the effective date of
	this Act if any element of the offense was committed before that
	date.
	SECTION 5.  This Act takes effect September 1, 2009.
	______________________________	______________________________
	President of the Senate	Speaker of the House
	I hereby certify that S.B. No. 449 passed the Senate on
	May 7, 2009, by the following vote:  Yeas 31, Nays 0.
	______________________________
	Secretary of the Senate
	I hereby certify that S.B. No. 449 passed the House on
	May 27, 2009, by the following vote:  Yeas 148, Nays 0, one
	present not voting.
	______________________________
	Chief Clerk of the House
	Approved:
	______________________________
	Date
	______________________________
	Governor